Categories AlphaGraphs, Cannabis, Earnings

Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results

Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens. The bottom-line was wider than the analysts’ expectations while the top-line missed consensus estimates.

The company posted a wider loss in the fourth quarter of 2020 due to impairment and restructuring charges. The top-line increased by 15% year-over-year backed by higher revenue from Canadian medical and International medical segments despite lower revenue from Canadian recreational revenue.

Canopy Growth (CGC) Q4 2020 earnings

Canopy Growth expects fiscal 2021 to be a transition year as the company resets its strategic focus, rolls out a new organizational design, and implements a comprehensive operational and supply chain productivity program. Given this, as well as the significant COVID-19 related uncertainties that exist, the company is withdrawing its previously communicated milestones for achieving positive adjusted EBITDA and net income.

Past Performance

Also Read:  CPB Earnings: Key highlights from Campbell Soup Q4 financial results announcement

Most Popular

COVID-19 drove retailers up the digital path years ahead than anticipated

Earlier we looked into how, during the COVID-19 pandemic, retailers saw changing trends in terms of their assortments and how the acceleration of online shopping led many of them to

Snowflake (SNOW) creates a record as the most successful software IPO ever; stock more than doubles

Data is at the heart of business innovation. Recognizing this trend, companies are seeking ways to transform their businesses by capturing, analyzing, and mobilizing data. The public cloud is becoming

Adobe (ADBE) sees new tailwinds as virtual shift gathers steam

The second half has been highly rewarding for design software maker Adobe Inc. (NASDAQ: ADBE) amid stable demand for digital content solutions. The company has remained unaffected by the virus-related

Top